Prothena Corp Public (PRTA) Current Deferred Tax Assets (2012 - 2015)
Prothena Corp Public (PRTA) posted quarterly Current Deferred Tax Assets of $174000.0 for Q3 2015, up 95.51% year-over-year from $89000.0 in Q3 2014, and up 5.45% quarter-over-quarter from $165000.0 in Q2 2015.
Prothena Corp Public (PRTA) Current Deferred Tax Assets (2012 - 2015) Analysis & Trends
Prothena Corp Public's Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $174000.0 for Q3 2015.
- In Q3 2015, Current Deferred Tax Assets rose 95.51% year-over-year to $174000.0; the TTM figure through Sep 2015 stood at $174000.0 (up 95.51% YoY), while the FY2014 annual figure was $167000.0, up 106.17% from the prior year.
- Current Deferred Tax Assets for Q3 2015 stood at $174000.0, up from $165000.0 in the prior quarter.
- The five-year high for Current Deferred Tax Assets was $267000.0 in Q3 2013, with the low at $73000.0 in Q4 2012.
- The 4-year median for Current Deferred Tax Assets is $85500.0 (2014), against an average of $123666.7.
- The sharpest annual moves came in 2014 and 2015: Current Deferred Tax Assets sank 66.67% in 2014, then surged 111.69% in 2015.
- Prothena Corp Public's Current Deferred Tax Assets stood at $73000.0 in 2012, then rose by 10.96% to $81000.0 in 2013, then jumped by 106.17% to $167000.0 in 2014, then climbed by 4.19% to $174000.0 in 2015.
- Business Quant data shows PRTA's Current Deferred Tax Assets at $174000.0 in Q3 2015, $165000.0 in Q2 2015, and $163000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 174,000.00 |
| Sep 30, 2015 | 174,000.00 |
| Jun 30, 2015 | 165,000.00 |
| Jun 30, 2015 | 165,000.00 |
| Mar 31, 2015 | 163,000.00 |
| Mar 31, 2015 | 163,000.00 |
| Dec 31, 2014 | 167,000.00 |
| Dec 31, 2014 | 167,000.00 |
| Sep 30, 2014 | 89,000.00 |
| Sep 30, 2014 | 89,000.00 |
| Jun 30, 2014 | 82,000.00 |
| Jun 30, 2014 | 82,000.00 |
| Mar 31, 2014 | 77,000.00 |
| Mar 31, 2014 | 77,000.00 |
| Dec 31, 2013 | 81,000.00 |
| Dec 31, 2013 | 81,000.00 |
| Sep 30, 2013 | 267,000.00 |
| Sep 30, 2013 | 267,000.00 |
| Jun 30, 2013 | 73,000.00 |
| Jun 30, 2013 | 73,000.00 |